Neuropace Inc (NPCE) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.19x
Neuropace Inc (NPCE) has a Cash Flow Reinvestment Rate of 0.19x as of December 2025, reinvesting $97.00K (capex $97.00K ) from operating cash flow of $506.00K. Explore reinvestment intensity of Neuropace Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.19x
(Capex + Investments) / Operating CF
Total Reinvested
$97.00K
Capex + Investments
Operating Cash Flow
$506.00K
USD
Capital Expenditures
$97.00K
USD
Annual Cash Flow Reinvestment Rate for Neuropace Inc (None–None)
Year-by-year capital reinvestment analysis for Neuropace Inc. For live market cap and broader valuation context, see NPCE stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow